Back

Future risk of bradyarrhythmias in patients with hypertrophic cardiomyopathy and implantable cardioverter defibrillator indication

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Arrhythmia in cardiomyopathy Prognosis and Risk Stratification ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Kosuke Nakasuka

National Cerebral & Cardiovascular Center, Suita (Japan)

9 More presentations in this session

Presentation thumbnail
Dilated cardiomyopathy - a group that does not benefit from ICD?
Doctor P. Silverio Antonio (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry
Professor G. Frommeyer (Munster, DE)
Abstract
Presentation thumbnail
Incidence of appropriate implantable cardioverter defibrillator therapy and sudden cardiac death in cardiac sarcoidosis - a systematic review and meta-analysis
Mr K. Franke (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Assessment of clinical risk factors for all-cause mortality among hypertrophic cardiomyopathy patients with ICDs.
Mr S. Mielczarek (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Predicting arrhythmic risk in dilated cardiomyopathy: a systematic review & meta-analysis of clinical parameters
Doctor A. Sammani (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Arrhythmia in cardiomyopathy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources